StockMarketWire.com - Health and nutrition business Benchmark said Thursday adjusted profits rose 19%, led by a jump in revenue from its genetics division.
For the 12 months ended 31 December, adjusted profit, which excluded exceptional cost, rose 19% to £5.6m and revenue increased by 8% to £151.5m.
Revenue growth was led by genetics up 21%; Advanced Nutrition up 9%; and Animal Health up 7%, the company said.
When exceptional costs related to initiation of new production facilities, increased finance and credit costs are included, pre-tax losses widened to £13.7m from £8.1m a year earlier.
Exceptional costs included a rise in depreciation, amortisation and impairment charges to £24.8m for the year, from £23.4m a year earlier, principally relating to the new production facilities coming on stream. While the increase in finance costs and a credit in exceptional costs in the prior year of £5.6m also weighed down performance.
Adjusted earnings (EBITDA) rose 68% to £17.0m, led by a 36% increase in Genetics, a 22% increase in Advanced Nutrition, the company said.
At 10:08am: [LON:BMK] Benchmark Holdings Plc share price was 0p at 58.5p
Story provided by StockMarketWire.com
Shares Magazine
Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.
Investor Events
Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.